Literature DB >> 8760408

Feline immunodeficiency virus can infect a human cell line (MOLT-4) but establishes a state of latency in the cells.

Y Ikeda1, K Tomonaga, Y Kawaguchi, M Kohmoto, Y Inoshima, Y Tohya, T Miyazawa, C Kai, T Mikami.   

Abstract

Infectivity of feline immunodeficiency virus (FIV) in feline and human lymphoblastoid cell lines was examined using homogeneous populations of FIV derived from infectious molecular clones of strains TMZ and Petaluma, and two recombinant chimeric clones carrying gag, pol, vif and ORF-A from the heterologous virus. FIV from the clones with the env region of the Petaluma strain was shown to infect and establish provirus in a human lymphoid cell line (MOLT-4), although the FIV-infected cells did not produce any infectious viruses. By treatment of the infected MOLT-4 cells with a phorbol ester, infectious virus was rescued. To examine which stage of the life-cycle of FIV is blocked in these cells, we analysed transcription of FIV-14 in the cells by RT-PCR. FIV-specific RNA expression could not be detected. These results strongly suggest that latency of the virus in MOLT-4 cells is due to a failure in transcription.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8760408     DOI: 10.1099/0022-1317-77-8-1623

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  14 in total

1.  Experimental mucosal infection with molecularly cloned feline immunodeficiency viruses.

Authors:  Mariko Kohmoto; Yasuhiro Ikeda; Eiji Sato; Yorihiro Nishimura; Yasuo Inoshima; Masayuki Shimojima; Yukinobu Tohya; Takeshi Mikami; Takayuki Miyazawa
Journal:  Clin Diagn Lab Immunol       Date:  2003-01

2.  Lack of functional receptors is the only barrier that prevents caprine arthritis-encephalitis virus from infecting human cells.

Authors:  L Mselli-Lakhal; C Favier; K Leung; F Guiguen; D Grezel; P Miossec; J F Mornex; O Narayan; G Querat; Y Chebloune
Journal:  J Virol       Date:  2000-09       Impact factor: 5.103

3.  Minimum requirements for efficient transduction of dividing and nondividing cells by feline immunodeficiency virus vectors.

Authors:  J C Johnston; M Gasmi; L E Lim; J H Elder; J K Yee; D J Jolly; K P Campbell; B L Davidson; S L Sauter
Journal:  J Virol       Date:  1999-06       Impact factor: 5.103

4.  Feline immunodeficiency virus xenoinfection: the role of chemokine receptors and envelope diversity.

Authors:  J B Johnston; C Power
Journal:  J Virol       Date:  2002-04       Impact factor: 5.103

5.  Primate and feline lentivirus vector RNA packaging and propagation by heterologous lentivirus virions.

Authors:  M T Browning; R D Schmidt; K A Lew; T A Rizvi
Journal:  J Virol       Date:  2001-06       Impact factor: 5.103

6.  Shared usage of the chemokine receptor CXCR4 by the feline and human immunodeficiency viruses.

Authors:  B J Willett; L Picard; M J Hosie; J D Turner; K Adema; P R Clapham
Journal:  J Virol       Date:  1997-09       Impact factor: 5.103

Review 7.  The neuropathogenesis of feline immunodeficiency virus infection: barriers to overcome.

Authors:  Nicola F Fletcher; Rick B Meeker; Lola C Hudson; John J Callanan
Journal:  Vet J       Date:  2010-04-24       Impact factor: 2.688

8.  Productive infection of human peripheral blood mononuclear cells by feline immunodeficiency virus: implications for vector development.

Authors:  J Johnston; C Power
Journal:  J Virol       Date:  1999-03       Impact factor: 5.103

9.  CXCR4 is required by a nonprimate lentivirus: heterologous expression of feline immunodeficiency virus in human, rodent, and feline cells.

Authors:  E M Poeschla; D J Looney
Journal:  J Virol       Date:  1998-08       Impact factor: 5.103

10.  Vpr counteracts the restriction of LAPTM5 to promote HIV-1 infection in macrophages.

Authors:  Li Zhao; Shumei Wang; Meng Xu; Yang He; Xiaowei Zhang; Ying Xiong; Hong Sun; Haibo Ding; Wenqing Geng; Hong Shang; Guoxin Liang
Journal:  Nat Commun       Date:  2021-06-17       Impact factor: 14.919

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.